Weight Loss Therapy (Semaglutide) TELEMED CONFERENCE REQUIRED
- 5mg Semaglutide
- FORM: Lyophilization or freeze drying is a process in which water is removed from a product after it is frozen and placed under a vacuum, allowing the ice to change directly from solid to vapor without passing through a liquid phase.
- Patient will add Reconstitution Solution (Bacteriostatic Water) to prepare for administration.
Semaglutide peptide therapy has taken the world by storm, along with a handful of other weight loss peptides. It’s been a long time since there has been a significant breakthrough in non-surgical weight loss treatments. Semaglutide offers amazing potential for weight loss, as well as for blood sugar control and for reducing heart disease risk factors in people with diabetes.
The peptide semaglutide is a GLP-1 receptor agonist, meaning that it increases the activity of the hormone GLP-1 in the body. GLP-1 is a key hormone related to metabolism, appetite, and blood glucose control, so GLP-1 receptor agonists can cause a number of direct and downstream effects that result in weight loss.
Semaglutide and other GLP-1 receptor agonists also activate these receptors far beyond the capabilities of the body’s endogenous (natural) GLP-1 .
The peptide works for weight loss and type 2 diabetes control by targeting both the pancreas and the digestive tract.
In the pancreas, it promotes the release of the hormone insulin—a key blood glucose regulating hormone. The body releases insulin in response to eating, and it shuttles excess blood glucose (sugar) into fat storage. Obesity and type 2 diabetes are both characterized by insulin resistance, which results in an increased insulin requirement to manage blood sugar levels.
Paired with a calorie-restricted diet and moderate exercise, which is recommended with Semaglutide Therapy, these effects can lead to weight loss, fat loss, insulin sensitivity, better metabolic health, and better cellular function.